• Health and wellness supplement producer HempFusion Wellness, Inc. is aggressively expanding its reach in retail outlets across the United States and internationally to cement its leadership position in the CBD industry and prepare it for further growth
• The company recently announced an agreement that will grant it 100 percent interest in successful CBD pioneer Sagely Naturals, which has built its brand on women-centric products
• Sagely Naturals is the third-most successful CBD brand and the most successful CBD topicals brand, with 23 percent market share in the drug channel and 13.8 percent market share in the multiple outlet channel
• The M&A agreement will grant Sagely Naturals access to international markets through HempFusion’s channels, while HempFusion will make a huge leap in domestic outlets through Sagely Naturals’ channels

An M&A agreement between health supplement innovator innovator HempFusion Wellness (TSX: CBD.U) (OTCQX: CBDHF) (FWB: 8OO) and women-centric CBD topicals powerhouse Sagely Enterprises, Inc. (“Sagely Naturals”) is expected to exponentially expand both brands’ market reach in domestic and international outlets. 

The merger and acquisition agreement, announced May 25, will grant HempFusion immediate access to an additional 14,000-plus stores where Sagely Naturals are sold, while Sagely Naturals will receive inclusion on HempFusion’s Novel Foods Application Dossier with the United Kingdom’s Regulatory Food Safety Agency for future European expansion.

“Upon closing, the acquisition of Sagely Naturals immediately adds significant value to shareholders,” HempFusion co-founder and CEO Jason Mitchell stated (https://ibn.fm/YbBA6). “By more than tripling our 2020 revenue (when combined with the closing of Apothecanna), expanding to over 15,000 stores, expanding our distribution strategy to six channels, combining some of the top executive talent in the industry, and bringing together over 75 incredible and best-selling SKUs, HempFusion is in its strongest position to date.”

The Apothecanna purchase agreement, announced May 17, will grant HempFusion access to the CBD brand’s distribution channel through 1,800 stores nationwide that include CVS and 7th Sense outlets (https://ibn.fm/7COnj). 

Sagely Naturals co-founders and Co-CEOs Kerrigan Behrens and Kaley Nichol also praised HempFusion’s focus on compliance with regulatory standards for hemp-derived products worldwide, with a nod to HempFusion’s distribution channels in mainland China, Hong Kong, Macau, Taiwan, Mexico, South Korea and the United Arab Emirates, as well as expectations of entering India, Ireland and the UK. 

“HempFusion approaches the industry the right way and possesses the resources required to help us significantly scale our business, increase our market share, and expand beyond our stronghold in the United States to international jurisdictions,” Behrens stated in the M&A announcement. 

Under the agreement, Behrens and Nichol will remain as co-CEOs of Sagely Naturals once the company becomes a subsidiary of HempFusion, maintaining the direction of their best-in-class marketing experience, proven innovation and strong consumer relationships that include A-list celebrities such as Cameron Diaz, Zoe Saldana and Molly Sims, who participate both as consumers and investors.

According to the news release, Sagely Naturals’ five SKUs have helped it maintain a position as the third-most successful CBD brand and leading CBD topicals brand, with 23 percent market share in the drug channel and 13.8 percent market share in the multiple outlet channel (“MULO”) and consistent growth even during the adverse conditions induced by the COVID pandemic during the past year. 

Its distribution outlets include key retailers such as CVS, Rite Aid, Albertsons, Sprouts and Nordstrom, as well as independent grocers and the company’s website. 

HempFusion’s branded products include broad-spectrum CBD oil tinctures, capsules and skin care focused on meeting consumer needs for sleep, stress, energy, and skin support. HempFusion also offers a line of over-the-counter topicals designed to target pain, eczema, acne and wound care. Its Probulin Probiotics, LLC, subsidiary produces probiotic products that target total gut health support and skin care, with some of the probiotic formulas targeting women’s and children’s needs, specifically.

For more information, visit the company’s website at www.HempFusion.com/corporate-information.

NOTE TO INVESTORS: The latest news and updates relating to HempFusion are available in the company’s newsroom at https://ibn.fm/CBDHF

About InvestorWire

InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent. We offer UNLIMITED Words on all domestic releases. While other wire services may provide a basic review of your release, InvestorWire helps you put your best foot forward with complimentary Press Release Enhancement.

With our competitors, the work is done the second your release crosses the wire. Not with InvestorWire. We include follow-up coverage of every release by leveraging the ever-expanding audiences of the 50+ brands that make up the InvestorBrandNetwork.

Get more out of your next press release with InvestorWire. It’s unlike anything you’ve seen before.

For more information, please visit https://www.investorwire.com

Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer

InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
www.investorwire.com
[email protected]

InvestorWire is part of the InvestorBrandNetwork.